The Role of Type H Vessels in Oral Diseases.

OBJECTIVE:This review aims to elucidate the biological significance of Type H vessels, a specialized bone marrow vascular subtype characterized by high expression of endothelial mucin (Emcn) and PECAM-1/CD31, and their critical role in coupling angiogenesis with osteogenesis. We also discuss their therapeutic potential in craniomaxillofacial trauma and alveolar bone loss. METHODS:This is a narrative review. we identified relevant studies by searching PubMed (MEDLINE) and Web of Science using combinations of keywords related to CD31/Endomucin (Type H Vessels), angiogenic-osteogenic coupling, and oral/craniofacial conditions, and by screening reference lists of key articles. RESULTS:The central role of Type H Vessels in skeletal biology underscores therapeutic promise for mitigating bone loss in periodontitis and other oral pathologies. CONCLUSIONS:Type H Vessels are emerging regulators of angiogenic-osteogenic coupling in skeletal tissues. Although bone and craniofacial tissues are similar and craniofacial evidence is growing, It remains less extensive than long-bone mechanistic studies; therefore, translational strategies in oral medicine should be interpreted in light of this evidence gap. This review consolidates mechanistic and clinical evidence, proposing novel strategies to harness the angiogenic-osteogenic coupling for oral rehabilitation of bone-destructive diseases. Future research should explore precise modulation of Type H Vessels to optimize therapeutic outcomes.